We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FOLLOW-ON BIOLOGICS GUIDANCE DELAYED, FDA DISPELS MISCONCEPTIONS
FOLLOW-ON BIOLOGICS GUIDANCE DELAYED, FDA DISPELS MISCONCEPTIONS
June 15, 2004
The FDA will not release its draft guidance detailing the scientific issues on follow-on biologics this summer as originally announced, according to a top agency official who also said the FDA will not approve generic biologics for products that can’t be characterized.